|

Welcome back to Mastering Medicinal
Chemistry - year six! This conference continues to offer a
quality, broad spectrum medicinal chemistry program with a
strong chemistry flavor delivered through case study, poster and
discussion group format.
This year’s program will feature early-
to late-stage programs across the therapeutic spectrum,
including the most aggressively pursued targets within each
group. Fragment-based design and screening approaches are
becoming an integral part of the medicinal chemistry approach
and will be featured extensively. An overall analysis of
outsourcing chemistry activities will be featured in-depth, as
well as discussion groups on solubility, the blood-brain-barrier
and much more.
See you in San Francisco!
Edel
PROGRAM OUTLINE
-
Chemistry Centric Case Studies
(structures shared) Across Several Topical Therapeutic Areas
Including:
-
Alzheimer’s Disease
-
Pain
-
Oncology
-
Diabetes & Obesity
-
Infection & HIV
-
Examples from Pre-Clinical
through Phase I, II and III (Pharma & Biotech)
-
Coverage of The Industry’s
Aggressively Pursued Targets from each Therapeutic Area
Including:
-
Gamma-secretase, BACE
-
TRPV1, CB1, Bradykinin, P1,
P2X3 & P2X7, Nicotinic Receptors
-
HDAC, c-Met, HER-2, VEGF,
Topoisomerase I&II, TNF-alpha
-
DPPIV, GLP-1, HSD1, MC3/MC4
-
Gag & pol polyprotein
processing enzymes, HCV
-
Fragment-based Inhibitor Design,
Screening and Optimization
-
How successful has FBDD been as
a platform for medicinal chemistry – case studies
-
How has FBDD inspired fresh
approaches in lead generation (small, soluble)
-
Special focus on optimization
of fragment hits
-
Technology in support of FBDD
-
Facing the challenge of
applying FBDD when structural information is not
available
-
Outsourcing Chemistry – The
Benefit to Biotech and Big Pharma
-
Insights on strategies across
different organizations
-
How is it impacting the growth
of Biotechs?
-
How successful is this activity
from the management perspective?
-
How is this working for the
bench chemist?
-
Panels & Discussion Group
Topics:
-
Solubility/ADME/ Permeability,
Polar Surface/BBB
-
The Trouble with Kinases –
Solubility for a Start
-
Medicinal Chemistry in Biotech
Today
-
Outsourcing Chemistry
-
Novel Synthetic Strategies – In
house and Outside
If you would like to submit a proposal
to give a presentation or display a poster at this meeting,
please submit a title and brief, 3-5 sentence summary of a
proposed topic on your recent work in the area of the medicinal
chemistry.
All proposals are subject to review
by the Scientific Advisory Committee to ensure the highest
quality of the conference program.
The deadline for submission is
August 1, 2008.
Please
click here
to submit your proposal.
For questions or suggestions about
the meeting, please contact:
Edel O'Regan
Cambridge Healthtech Institute
250 First Avenue, Suite #300
Needham, MA 02494
Tel: 781-972-5423
Fax: 781-972-5425
email:
eoregan@healthtech.com
For sales information, contact:
Carol Dinerstein
Tel: 781-972-5471
email:
dinerstein@healthtech.com
OR
Jon Stroup
Tel: 781-972-5483
email:
jstroup@healthtech.com
|
Corporate Sponsors


Lead Sponsoring
Publications





|